212 related articles for article (PubMed ID: 30646801)
1. Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.
Tsujimoto T; Kajio H
J Am Heart Assoc; 2019 Jan; 8(2):e011207. PubMed ID: 30646801
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
3. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
Khan AA; Chung MJ; Novak E; Brown DL
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
[TBL] [Abstract][Full Text] [Related]
4. Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease.
Tsujimoto T; Kajio H
Sci Rep; 2019 Mar; 9(1):3502. PubMed ID: 30837527
[TBL] [Abstract][Full Text] [Related]
5. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
[TBL] [Abstract][Full Text] [Related]
6. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Brooks MM; Chaitman BR; Nesto RW; Hardison RM; Feit F; Gersh BJ; Krone RJ; Sako EY; Rogers WJ; Garber AJ; King SB; Davidson CJ; Ikeno F; Frye RL;
Circulation; 2012 Oct; 126(17):2115-24. PubMed ID: 23008442
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
9. Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Dec; 273():1-7. PubMed ID: 30082118
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
11. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
12. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
[TBL] [Abstract][Full Text] [Related]
14. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Chung MJ; Novak E; Brown DL
Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
[TBL] [Abstract][Full Text] [Related]
15. Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2019 May; 282():1-6. PubMed ID: 30772014
[TBL] [Abstract][Full Text] [Related]
16. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
17. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.
Gurewich V
Cardiovasc Drugs Ther; 2019 Dec; 33(6):749-753. PubMed ID: 31897763
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.
Mansur Ade P; Hueb WA; Takada JY; Avakian SD; Soares PR; Garzilo CL; Kalil Filho R; Ramires JA
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):997-1001. PubMed ID: 25183741
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.
Kamalesh M; Sharp TG; Tang XC; Shunk K; Ward HB; Walsh J; King S; Colling C; Moritz T; Stroupe K; Reda D;
J Am Coll Cardiol; 2013 Feb; 61(8):808-16. PubMed ID: 23428214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
